Primary lymphoepithelioma-like carcinoma of salivary gland: Sixty-nine cases with long-term follow-up

Head and Neck

Volumn 36, Issue 9, 2014, Pages 1305-1312

  Ma, Huali ^a   Lin, Yongbin ^a   Wang, Liang ^a   Rao, Huilan ^a   Xu, Guangchuan ^a   He, Youjian ^a   Liang, Ying ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

lymphoepithelioma like carcinoma; neck dissection; neutrophil lymphocyte ratio; postoperative radiotherapy; salivary gland

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; NEDAPLATIN; TEGAFUR; TUMOR MARKER;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPHOCYTE; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NEUTROPHIL; OVERALL SURVIVAL; PAROTID GLAND; PAROTIDECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SALIVARY GLAND CARCINOMA; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; ADJUVANT THERAPY; ADOLESCENT; AGED; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHILD; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SALIVARY GLAND NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906087777     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23450     Document Type: Article

References (50)

1. Iezzoni JC, Gaffey MJ, Weiss LM,. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 1995; 103: 308-315.
2. Hilderman WC, Gordon JS, Large HL Jr, Carrol CF Jr,. Malignant lymphoepithelial lesion with carcinomatous component apparently arising in parotid gland. A malignant counterpart of benign lymphoepithelial lesion? Cancer 1962; 15: 606-610.
3. Saku T, Cheng J, Jen KY, et al. Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asia area: a clinicopathologic study of 160 cases. Arkh Patol 2003; 65: 35-39.
4. Saw D, Lau WH, Ho JH, Chan JK, Ng CS,. Malignant lymphoepithelial lesion of the salivary gland. Hum Pathol 1986; 17: 914-923.
5. Schneider M, Rizzardi C,. Lymphoepithelial carcinoma of the parotid glands and its relationship with benign lymphoepithelial lesions. Arch Pathol Lab Med 2008; 132: 278-282.
6. Tsai CC, Chen CL, Hsu HC,. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol 1996; 27: 258-262.
7. Kuo T, Hsueh C,. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology 1997; 31: 75-82.
8. Pambuccian SE, Stelow EB, Koutlas IG, Thrall MJ,. Head and neck pathology: new developments in the diagnosis and pathogenesis of head and neck tumors. Patholog Res Int 2011; 2011: 354747.
9. Hui KK, Luna MA, Batsakis JG, Ordõñez NG, Weber R,. Undifferentiated carcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol 1990; 69: 76-83.
10. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME,. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 1319-1326.
11. Theriault C, Fitzpatrick PJ,. Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 1986; 9: 510-516.
12. Wang CP, Chang YL, Ko JY, Lou PJ, Yeh CF, Sheen TS,. Lymphoepithelial carcinoma versus large cell undifferentiated carcinoma of the major salivary glands. Cancer 2004; 101: 2020-2027.
13. Sheen TS, Tsai CC, Ko JY, Chang YL, Hsu MM,. Undifferentiated carcinoma of the major salivary glands. Cancer 1997; 80: 357-363.
14. Hsiung CY, Huang CC, Wang CJ, Huang EY, Huang HY,. Lymphoepithelioma-like carcinoma of salivary glands: treatment results and failure patterns. Br J Radiol 2006; 79: 52-55.
15. Hsu YC, Lu HF, Huang CC, Hsu RF, Su CY,. Malignant lymphoepithelial lesions of the salivary gland. Otolaryngol Head Neck Surg 2006; 134: 661-666.
16. Xiao P, Huang J, Zhang X, Zou Y,. [Diagnosis and management in parotid lymphoepithelioma-like carcinoma]. [Article in Chinese] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008; 22: 651-653.
17. Cai YL, Wang ZH, Lu SJ,. [Analysis for therapy and prognosis of undifferentiated carcinoma with lymphoid stroma in salivary gland]. [Article in Chinese] Shanghai Kou Qiang Yi Xue 2002; 11: 310-313.
18. Zhang Q, Qing J, Wei MW, Guo ZM,. [Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland]. [Article in Chinese] Ai Zheng 2005; 24: 1384-1387.
19. Niedobitek G, Herbst H,. In situ detection of Epstein-Barr virus DNA and viral gene products. Methods Mol Biol 2001; 174: 79-91.
20. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999; 59: 1188-1191.
21. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350: 2461-2470.
22. Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 2010; 13: 170-176.
23. Nagao T, Ishida Y, Sugano I, et al. Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion. Cancer 1996; 78: 695-703.
24. Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G,. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol 1991; 22: 811-815.
25. Krishnamurthy S, Lanier AP, Dohan P, Lanier JF, Henle W,. Salivary gland cancer in Alaskan natives, 1966-1980. Hum Pathol 1987; 18: 986-996.
26. Nielsen NH, Mikkelsen F, Hansen JP,. Incidence of salivary gland neoplasms in Greenland with special reference to an anaplastic carcinoma. Acta Pathol Microbiol Scand A 1978; 86: 185-193.
27. Kotsianti A, Costopoulos J, Morgello S, Papadimitriou C,. Undifferentiated carcinoma of the parotid gland in a white patient: detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1996; 27: 87-90.
28. Herbst H, Niedobitek G,. Sporadic EBV-associated lymphoepithelial salivary gland carcinoma with EBV-positive low-grade myoepithelial component. Virchows Arch 2006; 448: 648-654.
29. Mrad K, Ben Brahim E, Driss M, Abbes I, Marakchi M, Ben Romdhane K,. Lymphoepithelioma-like carcinoma of the submandibular salivary gland associated with Epstein-Barr virus in a North African woman. Virchows Arch 2004; 445: 419-420.
30. Abdelkrim SB, Trabelsi A, Hammedi F, et al. Primary lymphoepithelial carcinoma of the parotid gland in a North African woman. Rare Tumors 2009; 1: e16.
31. Twu CW, Wang WY, Liang WM, et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 130-137.
32. Neel HB III, Pearson GR, Taylor WF,. Antibody-dependent cellular cytotoxicity. Relation to stage and disease course in North American patients with nasopharyngeal carcinoma. Arch Otolaryngol 1984; 110: 742-747.
33. Neel HB III, Taylor WF,. Epstein-Barr virus-related antibody. Changes in titers after therapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1990; 116: 1287-1290.
34. de-Vathaire F, Sancho-Garnier H, de-Thé H, et al. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 1988; 42: 176-181.
35. Chen ZX, Zhang Q, Guo ZM, Wei MW, Yang AK,. [Clinical analysis of salivary malignant pleomorphic adenoma-a report of 95 cases]. [Article in Chinese] Ai Zheng 2006; 25: 1144-1148.
36. Lu ZH, Yang AK, Chen ZX, Song M, Wei MW,. [Prognostic analysis of 116 patients with mucoepidermoid carcinoma of the parotid gland]. [Article in Chinese] Ai Zheng 2007; 26: 752-755.
37. Qing J, Zhang Q, Wei MW, Guo ZM,. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases]. [Article in Chinese] Ai Zheng 2006; 25: 1138-1143.
38. Arthaud JB,. Anaplastic parotid carcinoma ("malignant lymphoepithelial lesion") in seven Alaskan natives. Am J Clin Pathol 1972; 57: 275-286.
39. Abdulla AK, Mian MY,. Lymphoepithelial carcinoma of salivary glands. Head Neck 1996; 18: 577-581.
40. Dubey P, Ha CS, Ang KK, et al. Nonnasopharyngeal lymphoepithelioma of the head and neck. Cancer 1998; 82: 1556-1562.
41. Agulnik M, McGann CF, Mittal BB, Gordon SC, Epstein JB,. Management of salivary gland malignancies: current and developing therapies. Oncol Rev 2008; 2: 86-94.
42. Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer 2012; 118: 4748-4758.
43. Mantovani A, Allavena P, Sica A, Balkwill F,. Cancer-related inflammation. Nature 2008; 454: 436-444.
44. Grivennikov SI, Greten FR, Karin M,. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
45. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E,. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137: 425-428.
46. Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007; 13: 902-911.
47. Wu Y, Zhao Q, Peng C, Sun L, Li XF, Kuang DM,. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 2011; 225: 438-447.
48. Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008; 32: 1757-1762.
49. Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H,. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 1998; 124: 329-334.
50. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M,. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007; 73: 215-220.